Omega-7 (Sea Buckthorn).

Palmitoleic acid carries a double bond that makes the oil susceptible to peroxidation, and alpha-tocopherol is the chain-breaking antioxidant that intercepts lipid peroxyl radicals. Sea buckthorn oil naturally carries tocopherols for the same reason, and added vitamin E extends that protection.

Cholecalciferol needs dietary fat to form mixed micelles before it crosses the enterocyte. Taking it with an oil such as sea buckthorn raises the fraction absorbed compared with a dry dose on an empty stomach.

MK-7 is a long-chain isoprenoid quinone that depends on micelle formation and chylomicron packaging for uptake. A co-dosed oil supplies the lipid that drives that step.

Sea buckthorn fruit oil carries beta-carotene and other carotenoids that BCO1 cleaves to retinal, and the oil itself supplies the fat carotenoid uptake requires. The pairing covers both the preformed and the provitamin side of the same pool.

Astaxanthin sits across the lipid bilayer with its polar ends anchored at both surfaces, which places it where unsaturated fatty acids oxidise. Formulated with an omega-7 oil it protects the oil and travels with it into the same lipoprotein fraction.

Palmitoleic acid is a monounsaturated 16-carbon fatty acid handled by different elongation steps than the long-chain omega-3s, so the two do not compete for desaturase capacity. Formulators combine them to cover both the mucosal-lipid and the eicosanoid-precursor roles.

Sea buckthorn berries carry ascorbate alongside their oil fraction, and the two sit on opposite sides of the same antioxidant network. Ascorbate regenerates the tocopheryl radical back to tocopherol in the lipid phase, which is what keeps an unsaturated oil's own vitamin E from being spent. Co-supplying vitamin C with a palmitoleic-rich oil supports that recycling loop. This is chemistry of the antioxidant network, not a measured clinical outcome.

Triacylglycerols in berry and seed oil are not absorbed intact. Pancreatic lipase cleaves them to monoacylglycerols and free fatty acids before micellar uptake, so lipase activity is the rate step for any oil-delivered fatty acid. Supplemental lipase is used in formulation where fat digestion is a limiting factor. The relationship is mechanical rather than an effect measured in a trial.

Bile salts emulsify dietary oil into micelles and present the products of lipolysis to the enterocyte surface. Where bile flow is low, fat-soluble material including a berry oil is absorbed less completely. Bile acid supplementation is a formulation answer to that specific step. No combination trial with sea buckthorn oil grounds this; the pharmacology is settled.

Phospholipids act as emulsifiers, dispersing an oil into fine droplets with far more surface area for lipase to work on. That is why lecithin-class emulsifiers appear in oil softgels and emulsions. With a sea buckthorn oil the practical effect is a more uniform dispersion in the gut lumen. It is a formulation relationship, not a claimed physiological effect.

Lecithin is the routine non-soy emulsifier in oil-filled capsules and liquid emulsions. It lowers interfacial tension so a viscous berry oil disperses rather than separating. Formulators reach for it when a sea buckthorn oil is delivered outside a plain softgel. The claim here is about the dosage form and nothing more.

Sea buckthorn oil carries a high share of unsaturated fatty acids, which are the substrate for lipid peroxidation chains. Tocopherols interrupt those chains by donating a hydrogen to the propagating peroxyl radical. They are added to oil products for that reason, and the berry oil contains its own. The role is oxidative stability of the oil itself.

Rosemary extract standardised for carnosic acid and rosmarinic acid is a widely used natural antioxidant in edible oils. It works in the lipid phase alongside tocopherols to slow peroxide formation during shelf life. In a sea buckthorn oil it is a stability ingredient rather than an active. Shelf stability of an oil is not the same as an effect in a person.

Lutein absorption improves when it is consumed with fat, because it partitions into mixed micelles alongside dietary lipid. A berry oil supplies that lipid at the same eating occasion. This is a general fat-soluble nutrient relationship rather than anything specific to omega-7. It says nothing about what either ingredient then does.

Lycopene is a highly lipophilic carotenoid with poor uptake from a low-fat meal. Co-ingested oil raises the amount that reaches the micellar phase. Sea buckthorn oil functions as that vehicle no differently from other food oils. The mechanism is absorption, not a combined action.

Phylloquinone is fat-soluble and its uptake tracks the fat content of the meal it arrives with. An oil capsule taken alongside supplies that fat. Nothing about omega-7 specifically drives this; it is the lipid phase doing the work. Included because co-dosing is frequent in multi-oil formulas.

Ubiquinone is poorly water-soluble and is routinely delivered dissolved or dispersed in an oil. Sea buckthorn oil can serve as that carrier in a softgel. The relationship is dissolution and delivery. It carries no implication that either ingredient changes the other's activity.

An omega-7 rich sea buckthorn oil and an omega-3 rich algal oil have been compared head to head on the same measured lipid endpoints, and the authors report the two differed by endpoint rather than behaving interchangeably. Palmitoleic acid is a monounsaturated 16-carbon fatty acid and DHA a 22-carbon polyunsaturate, and they enter membrane and lipid handling at different points. Combining them may broaden the fatty acid spectrum a formula supplies, which is an inference from composition rather than something the comparison tested. The work was preclinical and reports measured lipid markers, which are markers and not clinical outcomes.

Several culinary and berry-derived plants have been catalogued in a systematic review for measured effects on platelet aggregation, and sea buckthorn appears in that literature. Stacking two such ingredients is an additive direction worth flagging rather than a benefit to advertise. Anyone already using something that influences clotting should raise the combination with their clinician. The review reports laboratory aggregation measures, which are markers and not clinical events.

Garlic constituents are among the most frequently reported plant modulators of platelet aggregation in that review literature. Taken alongside a berry oil with its own reported aggregation effects, the direction is additive. This is a flag for combined use, not a recommendation. Aggregation in a laboratory assay is a marker, not a measured clinical event.

Nattokinase is taken specifically for its reported fibrinolytic activity. Adding an oil that has itself been examined for platelet effects pushes in the same direction. Nobody has run the pair together, and the caution stands on the individual pharmacology of each. Flagging an additive direction is the honest handling here.

Sea buckthorn fruit carries flavonols including quercetin glycosides alongside its oil fraction, so the pairing reproduces something the whole berry already does. Flavonols act in the aqueous phase and tocopherols in the lipid phase, which is why they are commonly formulated together. Whole-berry preparations differ from a pressed oil in this respect. Composition is well described; a combined effect in people is not.

Carotenoids give sea buckthorn pulp oil its deep orange colour, and beta-carotene is among them. As a fat-soluble provitamin it depends on a lipid phase for uptake, which the oil supplies. The pairing therefore mirrors the intact fruit. This describes delivery, not an added effect.

Broad-spectrum enzyme blends include lipase, which is the enzyme that liberates fatty acids from an ingested oil. Where fat digestion is incomplete, an oil passes through less well absorbed. Enzyme blends are used in formulas for exactly that reason. It is a digestion step, not a claim about what the fatty acids do afterwards.

Tocotrienols distribute readily within membranes and act as chain-breaking antioxidants in the lipid phase, the same phase an unsaturated berry oil occupies. Together with tocopherols they form the vitamin E family used to protect oils. Co-delivery is standard practice in oil-based products. The evidence here is chemistry, not a combination trial.